S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karen H. Albritton, MD
Dana-Farber Cancer Institute
Study Chair - R. Lor Randall, MD, FACS
University of Utah
Study Chair - Scott M. Schuetze, MD, PhD
University of Michigan Rogel Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
101 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California Davis Cancer Center
Davis, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado, United States
- Montrose Memorial Hospital Cancer Center
Montrose, Colorado, United States
- St. Anthony North Hospital
Westminster, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
- St. Francis Hospital and Health Centers
Beech Grove, Indiana, United States
- Mcfarland Clinic, P.C.
Ames, Iowa, United States
- Baton Rouge General Regional Cancer Center
Baton Rouge, Louisiana, United States
- Mary Bird Perkins Cancer Center - Baton Rouge
Baton Rouge, Louisiana, United States
- Mbccop - Lsu Health Sciences Center
New Orleans, Louisiana, United States
- Medical Center of Louisiana - New Orleans
New Orleans, Louisiana, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
- Mecosta County General Hospital
Big Rapids, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Lacks Cancer Center at Saint Mary'S Mercy Medical Center
Grand Rapids, Michigan, United States
- Metropolitan Hospital
Grand Rapids, Michigan, United States
- Spectrum Health Cancer Care - Butterworth Campus
Grand Rapids, Michigan, United States
- Spectrum Health Hospital - Blodgett Campus
Grand Rapids, Michigan, United States
- Holland Community Hospital
Holland, Michigan, United States
- Hackley Hospital
Muskegon, Michigan, United States
- Northern Michigan Hospital
Petoskey, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- Ccop - Montana Cancer Consortium
Billings, Montana, United States
- Deaconess Billings Clinic - Downtown
Billings, Montana, United States
- Deaconess Billings Clinic Cancer Center
Billings, Montana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2003
- Primary completion
- 31 Jul 2007
- Completion
- 31 Aug 2009
- Last update posted
- 6 Nov 2017
- Registered enrollment
- 24
- Registry id
- NCT00068367
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.